Source: Health Canada shortage reports · Updated Jul 20, 2026
Some Codeine products are in shortage in Canada (1 of 5 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 30, 2026.
An opioid used to relieve mild to moderate pain and to suppress cough.
Products affected
1 / 5
In shortage since
Apr 15, 2026
Est. full return
Jul 30, 2026
Reports on file
23
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-CODEINE
15MG · TABLET · TEVA CANADA LIMITED
DIN 00593435 · since Apr 15, 2026, est. end Jul 30, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-CODEINE
30MG · TABLET · TEVA CANADA LIMITED
DIN 00593451 · ended Apr 21, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-CODEINE
15MG · TABLET · TEVA CANADA LIMITED
DIN 00593435 · ended Mar 18, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-CODEINE
30MG · TABLET · TEVA CANADA LIMITED
DIN 00593451 · ended Feb 27, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-CODEINE
30MG · TABLET · TEVA CANADA LIMITED
DIN 00593451 · ended Feb 25, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-CODEINE
15MG · TABLET · TEVA CANADA LIMITED
DIN 00593435 · ended Oct 29, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-CODEINE
30MG · TABLET · TEVA CANADA LIMITED
DIN 00593451 · ended Aug 27, 2025 · Disruption of the manufacture of the drug.
To be discontinued
CODEINE 30
30MG · TABLET · LABORATOIRE RIVA INC.
DIN 02009757
Resolved
TEVA-CODEINE
30MG · TABLET · TEVA CANADA LIMITED
DIN 00593451 · ended Jun 4, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-CODEINE
15MG · TABLET · TEVA CANADA LIMITED
DIN 00593435 · ended Jun 8, 2023 · Disruption of the manufacture of the drug.
Resolved
CODEINE 30
30MG · TABLET · LABORATOIRE RIVA INC.
DIN 02009757 · ended Mar 13, 2023 · Shortage of an inactive ingredient or component.
Resolved
TEVA-CODEINE
30MG · TABLET · TEVA CANADA LIMITED
DIN 00593451 · ended Dec 21, 2022 · Disruption of the manufacture of the drug.
Showing 12 of 23 reports. All reports are on file with Health Canada.
What's happening
Codeine is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Codeine is classified under “COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS” (ATC R05DA).
Recent changes
Jul 20, 2026
Estimated end date pushed back : Jul 10, 2026 → Jul 30, 2026
Common questions
What is Codeine used for?
An opioid used to relieve mild to moderate pain and to suppress cough.
When will Codeine be back in stock in Canada?
The latest manufacturer estimate is Jul 30, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Codeine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.